Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000494:pharmacology* / Q000633:toxicity; D001419:Bacteria / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology / Q000633:toxicity; D006863:Hydrogen-Ion Concentration; D007928:Lethal Dose 50; D008034:Lincomycin / Q000494:pharmacology; D051379:Mice; D008826:Microbial Sensitivity Tests; D008847:Micromonospora / Q000378:metabolism; D009174:Mycoplasma / Q000187:drug effects; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D010406:Penicillins; D004917:Erythromycin; D008034:Lincomycin; D013752:Tetracycline